Portola Pharma

Portola Pharma

Portola Pharma

Portola (Nasdaq: PTLA) is a biopharma co. focused on developing life-saving therapeutics in thrombosis and hematology.  Twitter policy on our site
Type
B2c
Founded
2003
Raised
$149.1M
Follow us
Alexa global traffic share
Twitter followers
Acquired by
Alexion Pharmaceuticals, Inc.
05 May 2020
$1,400,000,000
Latest funding
$89,000,000
Venture capital (Series D) - 2011
Temasek Holdings Eastern Capital
MedCity News

Alexion plunks down $1.4B to acquire Portola Pharmaceuticals